Closed petition Ensure UK cancer patients retain access to the latest treatments after Brexit

The European Commission has made it clear it would see a post-Brexit UK as falling outside EU regulations on clinical trials and the licensing of new medications.

More details

This could cause significant delay, or even prevent, cancer patients receiving essential life extending medications following a no-deal.

The Government should ensure that cancer patients in the UK retain access to clinical trials taking place across the EU and to any newly approved treatments.

This petition closed early because of a General Election Find out more on the Petitions Committee website

10,743 signatures

Show on a map

100,000

Government will respond

Government responds to all petitions that get more than 10,000 signatures

Waiting for a new Petitions Committee after the General Election